Olema Oncology, a clinical-stage biopharmaceutical company specializing in targeted breast cancer therapies, has officially changed its corporate name from Olema Pharmaceuticals, Inc. to Olema Oncology, Inc. This change, effective immediately, aligns the company's identity with its focus on oncology. The company's stock will continue trading on Nasdaq under the ticker OLMA, with no action needed from shareholders. Olema is advancing promising treatments including palazestrant in Phase 3 trials and OP-3136 in Phase 1, aiming to improve outcomes for cancer patients.
Olema Oncology's corporate name change is presented here with a snapshot of the health sector on Pluang as of Nov 12, 2026 20:12 WIB. Among 150 priced health-sector US stocks, 82 rose and 64 fell today. Takeda Pharmaceutical (TAK) saw a 2.45% increase to USD 21.35 with a 12-day typical hold time and 100% buy order activity, contrasting with Illumina (ILMN), which dropped 2.32% to USD 208.00 and has a much longer typical hold time of 85 days. AbCellera Biologics (ABCL) declined 2.51% to USD 11.65, with a 42-day hold time and predominantly buy orders at 74%.
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...
